# Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

> **NCT01178931** · NA · COMPLETED · sponsor: **University of Zagreb** · enrollment: 853 (actual)

## Conditions studied

- Luteal Phase Defect

## Interventions

- **DRUG:** Oral dydrogesterone
- **DRUG:** Crinone 8% gel

## Key facts

- **NCT ID:** NCT01178931
- **Lead sponsor:** University of Zagreb
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 853 (ACTUAL)
- **Last updated:** 2014-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01178931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01178931, "Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT01178931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*